Myocardial infarction with nonobstructive coronary arteries: the need for precision medicine

Curr Opin Cardiol. 2022 Nov 1;37(6):481-487. doi: 10.1097/HCO.0000000000000998. Epub 2022 Sep 12.

Abstract

Purpose of review: Myocardial infarction with nonobstructive coronary arteries (MINOCA) represents about 6-8% of all patients with myocardial infarction (MI), and several pathophysiological mechanisms showed to be involved in this heterogeneous clinical condition. Of note, MINOCA proved to be associated with a significant risk of mortality, angina burden and socioeconomic costs.

Recent findings: Results from randomized clinical trials evaluating the clinical effectiveness of a comprehensive diagnostic algorithm, along with the acute and long-term management of patients with MINOCA, are pending.

Summary: In this review article, we aim at providing an overview of the clinical features, diagnostic work-up and the therapeutic management of patients presenting with MINOCA, highlighting the recent acquisition along with the remaining important knowledge gaps in this field.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Coronary Angiography
  • Coronary Artery Disease* / therapy
  • Coronary Vessels / diagnostic imaging
  • Humans
  • MINOCA
  • Myocardial Infarction* / diagnosis
  • Myocardial Infarction* / therapy
  • Precision Medicine
  • Risk Factors